Registration Frequencies
Weekly updated frequencies of observation starts at registration by medication are shown.
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: 17. November | total n= 28,188
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: 17. November | total n= 28,188

Show table for Fig. 1/2Hide table
| Inclusion Treatment | Patient Number | of that with similar agents (e.g. Biosimilars) |
|---|---|---|
| Adalimumab | 1102 | 1709 |
| Bimekizumab | 546 | 0 |
| Brodalumab | 613 | 0 |
| Certolizumab | 256 | 0 |
| Efalizumab | 35 | 0 |
| Etanercept | 312 | 72 |
| Golimumab | 25 | 0 |
| Guselkumab | 2366 | 0 |
| Infliximab | 102 | 1 |
| Ixekizumab | 1190 | 0 |
| Risankizumab | 2464 | 0 |
| Secukinumab | 2334 | 0 |
| Tildrakizumab | 2052 | 0 |
| Ustekinumab | 786 | 84 |
| Apremilast | 819 | 0 |
| Ciclosporin | 402 | 0 |
| Deucravacitinib | 341 | 0 |
| Fumaric acid esters | 2694 | 0 |
| Dimethyl fumarate | 3590 | 0 |
| Methotrexate | 3926 | 0 |
| Tofacitinib | 2 | 0 |
| Upadacitinib | 9 | 0 |
| other systemics | 356 | 0 |
Fig. 3) Rate of patients by medication class at inclusion
Last update: 17. November | total n= 28,188

Fig. 4) Rate of patients by type of registry site
Last update: 17. November | total n= 28,188

Fig. 5) Registered PsoBest centers
Last update: 17. November| n= 1,217 | updated monthly









BVDD – Association of German Dermatologists
CVderm – German Center for Health Services Research in Dermatology
DDG – German Society of Dermatology
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP®)
German Network Healthcare Services Research
IVDP – Institute for Health Services Research in Dermatology and Nursing
PsoNet – Regional Psoriasis Networks in Germany
Psonet (EU) – network of EU registries of patients suffering from psoriasis or psoriatic arthritis, being treated by systemic agents